Study looks at effectiveness of pharmacist-delivered MAT to treat opioid use disorder

OPIOID STUDY: Susan Lim, site manager, and Joe Robillard, pharmacy technician, work on prescription orders at a Genoa Healthcare pharmacy inside a Gateway Healthcare clinic in Pawtucket. Genoa is collaborating with Rhode Island Hospital and CODAC Behavioral Healthcare on a study examining the effectiveness of pharmacist-delivered, medication-assisted treatment for opioid-use disorder.
 / PBN PHOTO/
RUPERT WHITELEY
OPIOID STUDY: Susan Lim, site manager, and Joe Robillard, pharmacy technician, work on prescription orders at a Genoa Healthcare pharmacy inside a Gateway Healthcare clinic in Pawtucket. Genoa is collaborating with Rhode Island Hospital and CODAC Behavioral Healthcare on a study examining the effectiveness of pharmacist-delivered, medication-assisted treatment for opioid-use disorder.
 / PBN PHOTO/
RUPERT WHITELEY

Efforts to curb the opioid epidemic include increasing access to care and reducing stigma, goals officials say a $1.6 million National Institutes of Health-funded, three-year study of pharmacy-administered, medication-assisted opioid addiction treatment promises to achieve. The study is a collaborative effort between Rhode Island Hospital, CODAC Behavioral Healthcare and Genoa Healthcare, seeking the effectiveness of

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber

No posts to display